Corvus Pharmaceuticals In...

AI Score

XX

Unlock

3.67
0.15 (4.26%)
At close: Apr 24, 2025, 3:59 PM
3.78
2.79%
After-hours: Apr 24, 2025, 07:59 PM EDT

Corvus Pharmaceuticals Statistics

Share Statistics

Corvus Pharmaceuticals has 68.14M shares outstanding. The number of shares has increased by 8.93% in one year.

Shares Outstanding 68.14M
Shares Change (YoY) 8.93%
Shares Change (QoQ) 6.04%
Owned by Institutions (%) 56.48%
Shares Floating 49.68M
Failed to Deliver (FTD) Shares 96
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 4.92M, so 7.22% of the outstanding shares have been sold short.

Short Interest 4.92M
Short % of Shares Out 7.22%
Short % of Float 8.78%
Short Ratio (days to cover) 6.13

Valuation Ratios

The PE ratio is -5.24 and the forward PE ratio is -19.64. Corvus Pharmaceuticals's PEG ratio is -0.06.

PE Ratio -5.24
Forward PE -19.64
PS Ratio 0
Forward PS 3.4
PB Ratio 10.02
P/FCF Ratio -12.83
PEG Ratio -0.06
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Corvus Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.03.

Current Ratio 1.54
Quick Ratio 1.54
Debt / Equity 0.03
Debt / EBITDA -0.04
Debt / FCF -0.04
Interest Coverage -15.1

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-2.01M
Employee Count 31
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax 0
Effective Tax Rate 0%

Stock Price Statistics

The stock price has increased by 147.97% in the last 52 weeks. The beta is 0.7, so Corvus Pharmaceuticals's price volatility has been higher than the market average.

Beta 0.7
52-Week Price Change 147.97%
50-Day Moving Average 3.86
200-Day Moving Average 5.17
Relative Strength Index (RSI) 56.11
Average Volume (20 Days) 679.93K

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -27.55M
Net Income -62.29M
EBITDA -27.55M
EBIT -60.47M
Earnings Per Share (EPS) -1.02
Full Income Statement

Balance Sheet

The company has 8.74M in cash and 1.12M in debt, giving a net cash position of 7.62M.

Cash & Cash Equivalents 8.74M
Total Debt 1.12M
Net Cash 7.62M
Retained Earnings -397.01M
Total Assets 68.91M
Working Capital 19M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -25.42M and capital expenditures 0, giving a free cash flow of -25.42M.

Operating Cash Flow -25.42M
Capital Expenditures 0
Free Cash Flow -25.42M
FCF Per Share -0.42
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

CRVS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for CRVS is $15, which is 308.7% higher than the current price. The consensus rating is "Buy".

Price Target $15
Price Target Difference 308.7%
Analyst Consensus Buy
Analyst Count 3
Stock Forecasts

Scores

Altman Z-Score -5.43
Piotroski F-Score 1